Concepedia

Philipp Oster

PO

Statistics

Publications

43

Citations

2.6K

H-Index

28

Active since

1999

Affiliations

Novartis (Italy)(Current)

Norwegian Institute of Public Health

Ministry of Health

New Zealand Institute for Public Health and Forensic Science

University of Auckland

Philipp Oster is an author at Novartis (Italy) specializing in medicine, vaccination, and infection control.

Top concepts

Publications per year

1999–2023

43

Publications

43

MeNZB?: a safe and highly immunogenic tailor-made vaccine against the New Zealand serogroup B disease epidemic strain

Philipp Oster, Diana Lennon, Jane O’Hallahan et al. · Vaccine · 2005 · 268 citations

, , +6

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

Jamie Findlow, Ray Borrow, Matthew D. Snape et al. · Clinical Infectious Diseases · 2010 · 255 citations

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

Matthew D. Snape, Tom Dawson, Philipp Oster et al. · The Pediatric Infectious Disease Journal · 2010 · 187 citations

The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease

J HOLST, Berit Feiring, L NASS et al. · Vaccine · 2005 · 103 citations

, , +9

The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB

Diana Martin, N. Ruijne, Lisa McCallum et al. · Clinical and Vaccine Immunology · 2006 · 103 citations · Full text

, , +17

1–5 of 43